Intelligence Profile
Clinical Applications
The clinical evidence for NAD+ IV infusion is extremely limited, with only a small number of published studies examining its therapeutic applications and safety profile.
Anti-Aging and Wellness Applications
One systematic review (2026) examined NAD+ supplementation for anti-aging and wellness purposes, though this review encompassed various forms of NAD+ supplementation including oral routes, not specifically IV infusion. The review's findings regarding IV-specific applications are not detailed in the available evidence.
Pharmacokinetic and Safety Studies
The most relevant clinical data comes from a pilot study (2019) that investigated changes in plasma and urine NAD+ metabolites during a 6-hour intravenous infusion of NAD+. This study appears to have focused primarily on understanding how IV NAD+ affects metabolite levels rather than therapeutic outcomes for specific conditions.
A retrospective tolerability study (2026) compared intravenous NAD+ infusion with oral nicotinamide riboside (NR) in a real-world clinical setting, suggesting that IV NAD+ is being used in clinical practice, though the specific conditions treated and efficacy outcomes are not detailed in the available abstracts.
Evidence Limitations
The clinical evidence base for NAD+ IV infusion is notably sparse. The available studies appear to focus primarily on pharmacokinetics, safety, and tolerability rather than demonstrating therapeutic efficacy for specific medical conditions. No large-scale randomized controlled trials specifically evaluating NAD+ IV infusion for defined clinical endpoints were identified in the evidence provided.
Important Note: This information is for educational purposes only and should not be considered medical advice. Consult with a qualified healthcare provider before considering any NAD+ IV therapy, as the clinical evidence remains limited and safety profiles are not fully established.
The lack of robust clinical trial data means that many claimed benefits of NAD+ IV infusion are not yet supported by high-quality evidence, and more research is needed to establish both efficacy and safety for specific therapeutic applications.